|
JPS6033478B2
(ja)
*
|
1980-06-20 |
1985-08-02 |
帝国臓器製薬株式会社 |
ペプチドの製造方法
|
|
US4708934A
(en)
|
1984-09-27 |
1987-11-24 |
Unigene Laboratories, Inc. |
α-amidation enzyme
|
|
US6319685B1
(en)
|
1984-09-27 |
2001-11-20 |
Unigene Laboratories, Inc. |
Alpha-amidating enzyme compositions and processes for their production and use
|
|
US4659804A
(en)
*
|
1984-11-01 |
1987-04-21 |
Armour Pharmaceutical Company |
(Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin
|
|
US4764589A
(en)
*
|
1987-05-26 |
1988-08-16 |
Rorer Pharmaceutical Corporation |
[N-alpha-acyl,8-glycine, des-19-leucine]-calcitonin
|
|
US5789234A
(en)
|
1987-08-14 |
1998-08-04 |
Unigene Laboratories, Inc. |
Expression systems for amidating enzyme
|
|
US5175146A
(en)
|
1989-12-05 |
1992-12-29 |
Vical, Inc. |
Synthetic calcitonin peptides
|
|
US5102666A
(en)
|
1990-09-11 |
1992-04-07 |
Oramed, Inc. |
Calcium polycarbophil controlled release composition and method
|
|
US5527790A
(en)
|
1991-09-30 |
1996-06-18 |
The University Of British Columbia |
Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US6692766B1
(en)
|
1994-06-15 |
2004-02-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Controlled release oral drug delivery system
|
|
JPH083196A
(ja)
|
1994-06-21 |
1996-01-09 |
Sanwa Kagaku Kenkyusho Co Ltd |
カルシトニン誘導体及びその用途
|
|
DE726075T1
(de)
|
1995-02-08 |
1996-12-12 |
Therapicon Srl |
Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
|
USRE39088E1
(en)
|
1995-08-22 |
2006-05-02 |
Japan Tobacco, Inc. |
Amide compounds and use of the same
|
|
US5962270A
(en)
*
|
1996-02-06 |
1999-10-05 |
Bionebraska, Inc. |
Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
RU2218407C2
(ru)
|
1997-04-16 |
2003-12-10 |
Юниджен Лэбораториз Инк. |
Прямая экспрессия пептидов в культуральные среды
|
|
CN1105726C
(zh)
*
|
1998-05-15 |
2003-04-16 |
中国科学院上海生物化学研究所 |
人降钙素类似物
|
|
AU1574900A
(en)
|
1998-12-04 |
2000-06-26 |
Provalis (Uk) Limited |
Pharmaceutical compositions containing insulin
|
|
JP2000290295A
(ja)
|
1999-03-31 |
2000-10-17 |
Asahi Chem Ind Co Ltd |
Ｎ−アセチルグルコサミニルカルシトニン
|
|
ES2235854T3
(es)
|
1999-04-05 |
2005-07-16 |
Emisphere Technologies, Inc. |
Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos.
|
|
US6780846B1
(en)
|
1999-09-27 |
2004-08-24 |
Elan Corporation, Plc |
Membrane translocating peptide drug delivery system
|
|
GB2368792A
(en)
|
2000-10-06 |
2002-05-15 |
Roger Randal Charles New |
Absorption enhancers
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
GB0109438D0
(en)
*
|
2001-04-17 |
2001-06-06 |
Isis Innovation |
Peptides
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
WO2004084870A1
(en)
|
2003-03-28 |
2004-10-07 |
Sigmoid Biotechnologies Limited |
Solid oral dosage form containing seamless microcapsules
|
|
GB0308732D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
|
PL1651249T3
(pl)
|
2003-07-23 |
2013-04-30 |
Novartis Ag |
Zastosowanie kalcytoniny w zapaleniu kości i stawów
|
|
EP1670500A2
(en)
|
2003-09-17 |
2006-06-21 |
Chiasma, Ltd. |
Compositions capable of facilitating penetration across a biological barrier
|
|
JP2008500281A
(ja)
|
2004-02-11 |
2008-01-10 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
アミリンファミリーペプチドおよびそれらを作成し使用するための方法
|
|
US7399744B2
(en)
|
2004-03-04 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition
|
|
CN101035547A
(zh)
|
2004-07-22 |
2007-09-12 |
蒂奥迈里克斯研究与指导有限公司 |
含巯基化合物作为流出泵抑制剂的用途
|
|
GB0422644D0
(en)
*
|
2004-10-12 |
2004-11-10 |
Novartis Ag |
Organic compounds
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
US7445911B2
(en)
|
2004-11-24 |
2008-11-04 |
Unigene Laboratories Inc. |
Enzymatic reactions in the presence of keto acids
|
|
EP1907561B1
(en)
|
2005-06-24 |
2013-08-28 |
Unigene Laboratories, Inc. |
Cell lines for expressing enzyme useful in the preparation of amidated products
|
|
JP5222727B2
(ja)
|
2005-09-06 |
2013-06-26 |
オーラメッド・ファーマスーティカルズ・インコーポレイテッド |
タンパク質を経口投与するための方法及び組成物
|
|
US8093207B2
(en)
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
PT1834635E
(pt)
|
2006-03-13 |
2011-10-13 |
Advanced In Vitro Cell Technologies S L |
Sistemas estáveis de nanocápsula para a administração de moléculas activas
|
|
BRPI0710503A2
(pt)
|
2006-04-07 |
2011-08-16 |
Merrion Res Iii Ltd |
uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
|
|
US8377863B2
(en)
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
|
US8962015B2
(en)
|
2007-09-28 |
2015-02-24 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
AU2010206614B2
(en)
|
2009-01-22 |
2015-03-26 |
Keybioscience Ag |
Treatment for obesity
|
|
BRPI1009392A2
(pt)
*
|
2009-03-12 |
2016-03-08 |
Nordic Bioscience As |
"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
|